ReviewFrontiers in neurology
The glia-neutrophil axis: an understudied crosstalk in bacteria-induced neuroinflammation.
Review in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Human neutrophilic cells express anti-inflammatory EBI3 in response to Neisseria meningitidis.Journal of neuroimmunology · 2026Article
- Human microglia express anti-inflammatory ISG15 in response to Neisseria meningitidis.Neuroscience letters · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bacterial infections of the central nervous system (CNS) are characterized by rapid and devastating neuroinflammation. While inflammation plays an important physiological role in defense against bacteria, such responses within the confines of the cranium can be lethal. Glial cells, including microglia and astrocytes, can perceive bacteria or their products and then respond in a manner that can promote inflammation, changes to blood-brain barrier integrity, and recruit leukocytes into the CNS. In this review, we have summarized their ability to produce chemotactic factors in response to bacterial components and clinically relevant bacterial pathogens of the CNS. Importantly, we have highlighted the fact that the chemotactic factors produced by bacterially challenged glia tend to preferentially recruit neutrophils, and we have described how such cells could then respond to the presence of bacteria to further promote glial activation and their own recruitment. This then, could form a vicious cycle that precipitates the rapid inflammatory CNS damage associated with bacterial infection. However, it is also becoming apparent that glia, and perhaps neutrophils, can adjust their responses to bacteria temporally in such a way as to break this positive feedback loop, and we have described the available evidence for the delayed production for anti-inflammatory mediators by these cells following challenge. Finally, we have discussed the present limitations in our understanding of these cell-cell interactions and their study that must be overcome before we can manipulate such a glia-neutrophil axis for therapeutic purposes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.